ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,01
-0,82%
Dow Jones
40 211,72
0,53%
DAX
18 464,63
-0,73%
Brent Oil
83,55
-0,94%
Bitcoin
62 799,11
-3,16%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Constellation Pharmaceuticals Inc (CNST)

  7. Constellation Pharmaceuticals Inc (CNST) Actualités

CNST

Constellation Pharmaceut... (CNST)

Constellation Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNST
DateHeureSourceTitreSymboleSociété
16/06/202123h21Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNSTConstellation Pharmaceuticals Inc
11/06/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of PelabresibNASDAQ:CNSTConstellation Pharmaceuticals Inc
05/06/202101h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSTConstellation Pharmaceuticals Inc
04/06/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202123h21Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202123h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202123h08Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202113h40GlobeNewswire Inc.Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSysNASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202113h25Business WireMorphoSys to Acquire Constellation PharmaceuticalsNASDAQ:CNSTConstellation Pharmaceuticals Inc
31/05/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/05/202113h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/05/202112h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
27/04/202117h30GlobeNewswire Inc.Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
23/04/202112h15Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
29/03/202121h15Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/03/202123h39Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202122h12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202113h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202112h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/02/202122h00GlobeNewswire Inc.Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
18/02/202116h00GlobeNewswire Inc.Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
16/02/202122h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/02/202121h22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSTConstellation Pharmaceuticals Inc
07/01/202115h30GlobeNewswire Inc.Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial OfficerNASDAQ:CNSTConstellation Pharmaceuticals Inc
06/01/202116h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
06/12/202014h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
23/11/202019h00GlobeNewswire Inc.Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 Pres...NASDAQ:CNSTConstellation Pharmaceuticals Inc
29/10/202012h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
19/10/202020h00GlobeNewswire Inc.Constellation Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2020 ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
09/09/202021h00GlobeNewswire Inc.Constellation Pharmaceuticals to Participate in Upcoming Virtual Investor ConferencesNASDAQ:CNSTConstellation Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNST

Dernières Valeurs Consultées

EU
AI
Air Liquide
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
EU
VIV
Vivendi
NYSE
MCD
McDonalds
EU
SGO
Cie de SaintGobain
EU
HO
Thales
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
EU
EN
Bouygues
EU
ML
Michelin
EU
VK
Vallourec
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés